Insulin responses to oral glucose during 4-year treatment with nifedipine retard in hypertensive patients with and without NIDDM.
Kazumi
T
T
Hozumi
T
T
Ishida
Y
Y
Yoshino
G
G
D000284:Administration, Oral; D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000503:physiopathology; D005947:Glucose / Q000008:administration & dosage*; D005951:Glucose Tolerance Test; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D009543:Nifedipine / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
D002121:Calcium Channel Blockers; D007328:Insulin; D009543:Nifedipine; D005947:Glucose